目录:杭州斯达特生物科技有限公司>>抗体/抗原>>Biosimilar抗体>> S0B0555Anti-PD-L1 Monoclonal Antibody(Atezolizumab)
Atezolizumab, sold under the brand name Tecentriq, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer （NSCLC）, small cell lung cancer （SCLC）, hepatocellular carcinoma and alveolar soft part sarcoma. It is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 （PD-L1）.
1
化工仪器网